Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Portfolio
  • Forum
  • Discovery
  • Q&A
  • About Us
    • Our Coverage
    • Team

Boule Diagnostics

3.90 SEK

-0.26 %

Less than 1K followers

BOUL

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Boule Diagnostics

2019202020212022202320242025
Revenue498.9400.5463.3548.1571.3558.5489.6
growth-%-19.7 %15.7 %18.3 %4.2 %-2.2 %-12.3 %
EBITDA70.0-5.936.029.039.3-257.432.0
EBIT70.0-5.936.029.039.3-257.422.3
Profit before taxes50.6-49.028.820.830.1-268.56.1
Net income37.5-48.023.312.725.0-223.3-3.5
EPS1.37-1.750.850.460.64-5.75-0.10
Dividend0.000.390.390.000.000.000.00
Dividend ratio0.0 %-22.2 %45.8 %0.0 %0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%14.0 %-1.5 %7.8 %5.3 %6.9 %-46.1 %6.5 %
EBIT-%14.0 %-1.5 %7.8 %5.3 %6.9 %-46.1 %4.6 %
ROE11.3 %-17.8 %7.9 %2.7 %5.3 %-82.8 %-2.1 %
ROI6.4 %-10.0 %4.1 %1.7 %3.3 %-37.8 %-0.7 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.